American Society of Clinical Oncology (ASCO) Treatment Algorithm for the Initial Hormonal Management of Androgen-Sensitive Advanced Cancer: 2007 Update

QualityTool

American Society of Clinical Oncology (ASCO) Treatment Algorithm for the Initial Hormonal Management of Androgen-Sensitive Advanced Cancer: 2007 Update

Description

This treatment algorithm for the initial hormonal management of androgen-sensitive advanced cancer is derived from the American Society of Clinical Oncology’s recommendations on hormone therapy for advanced prostate cancer.

This one-page tool provides recommendations in the following areas:

  • Discuss treatment options and early vs. late androgen ablation with patients
    • Bilateral orchiectomy
    • Luteinizing hormone-releasing hormone (LHRH) agonists
    • Nonsteroidal antiandrogen (NSAA) monotherapy
    • Combined androgen blockade
  • Review early androgen deprivation therapy (ADT) study results with patients and determine best treatment approach for patients with metastatic or progressive disease

Developer:

American Society of Clinical Oncology

Funding Sources:

American Society of Clinical Oncology

History

Release Date: 2007
Original Summary: August 2007
Last Updated: 04/10/13

Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.